BiomX
0 followers
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer.
Org chart
Jonathan Solomon
CEO and Board Member
Jonathan Solomon
Collapse
Merav Bassan
CDO
Regis A. Vilchez
SVP, Head of Clinical Development
Inbal Benjamini-Elran
VP, HR
Ariel Cohen
VP Development Projects
Edward Burd
Senior Vice President Regulatory Affairs
Eyal Weinstock
Senior Director and Co-founder
Myriam Golembo
VP Regulatory Affairs
Vered Lev
VP CMC
David Shiri
Director Of Operations
Evgenia (Jenia) Gold
Microbiology Team Leader at Assay Development
lina shpirt
Drug product team leader
Yifat Elharar
Team Leader
Adan Miari
Research Assistant
Chen Klein
Research Assistant
Eyal Ben-Dor Cohen
Drug Product Scientist
Gal Eylon-Ell
Research Assistant
Gal Raskin
Research Assistant
Hadar Cheriker
Research And Development Scientist
Hadar Fairstein
Process Development Scientist
Hila Sberro Livnat
Data Science Research Team Leader
Ilya Vainberg Slutzkin
Senior data science engineer
Inbal Levy
Team Lead, Molecular Biology Assay Development
Maayan Amar Ben-dalak
Senior Scientist
Maayan Ben Shimol
Process Development Scientist
Maya Olshina
Research Team Leader
Naama Knafo
DS Process Development R&D - Senior Scientist
Nufar Buchshtab
Research Team Leader in bio-tech
Svetlana Bruzil
Scientist
Tim Axelrod
Senior Researcher
Shachar Haran
QA Specialist
Chen Piller
Scientist - Assay Development
Eden Aviv
CMC Scientist
